Alphyn Biologics

Cincinnati, United States

Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.

$25.0M raised

Dec 2025

Series B

Health Care Life Science Pharmaceutical Therapeutics

Top Investors

Queen City AngelsAngel Physicians FundSerial Stage Venture Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alphyn Biologics

How much funding has Alphyn Biologics raised?

Alphyn Biologics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.

Who are Alphyn Biologics's investors?

Alphyn Biologics's investors include Queen City Angels, Angel Physicians Fund, Serial Stage Venture Partners.

Where is Alphyn Biologics headquartered?

Alphyn Biologics is headquartered in Cincinnati, United States.

What does Alphyn Biologics do?

Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.

What stage is Alphyn Biologics at?

Alphyn Biologics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2025.

MLA

"Alphyn Biologics — Funding & Investors." VCBacked, December 12, 2025, https://www.vcbacked.co/company/alphyn-biologics. Accessed June 17, 2026.

APA

VCBacked. (2025). Alphyn Biologics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/alphyn-biologics

Wikipedia (cite web)

{{cite web |title=Alphyn Biologics — Funding & Investors |url=https://www.vcbacked.co/company/alphyn-biologics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2025.

Similar Companies in Health Care